We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$683M
AUM Growth
-$101M
Cap. Flow
-$82.5M
Cap. Flow %
-12.08%
Top 10 Hldgs %
52.33%
Holding
153
New
26
Increased
35
Reduced
53
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$20M
2
BIIB icon
Biogen
BIIB
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.32M
4
ORA icon
Ormat Technologies
ORA
+$5.09M
5
OPK icon
Opko Health
OPK
+$5.01M

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$29.2M
2
SHPG
Shire pic
SHPG
+$27M
3
AGN
Allergan plc
AGN
+$23M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
VTRS icon
Viatris
VTRS
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 60.65%
2 Utilities 5.79%
3 Technology 1.86%
4 Consumer Discretionary 1.38%
5 Communication Services 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMTX
76
DELISTED
Dimension Therapeutics, Inc
DMTX
$2.26M 0.33%
+200,000
New +$2.53M
MDCO
77
DELISTED
Medicines Co
MDCO
$2.24M 0.33%
+60,000
New +$2.27M
CTSH icon
78
Cognizant
CTSH
$24.9B
$2.2M 0.32%
+36,600
New +$2.36M
DVAX
79
DELISTED
Dynavax Technologies
DVAX
$2.17M 0.32%
90,000
-10,000
-10% -$250K
VTAE
80
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$2.17M 0.32%
+120,000
New +$1.65M
PTCT icon
81
PTC Therapeutics
PTCT
$5.68B
$2.14M 0.31%
66,020
+62,020
+1,551% +$1.83M
PTN
82
Palatin Technologies
PTN
$13.7M
$2.08M 0.3%
2,506
-181
-7% -$167K
CYNA
83
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$2.07M 0.3%
134,037
-54,893
-29% -$834K
ABUS icon
84
Arbutus Biopharma
ABUS
$857M
$2.02M 0.3%
454,500
-50,500
-10% -$277K
ABEO icon
85
Abeona Therapeutics
ABEO
$366M
$2.02M 0.3%
24,000
– –
AXSM icon
86
Axsome Therapeutics
AXSM
$11.2B
$2.01M 0.29%
+220,000
New +$1.94M
PDSB icon
87
PDS Biotechnology
PDSB
$38.4M
$1.94M 0.28%
+7,750
New +$2.5M
SCYX icon
88
SCYNEXIS
SCYX
$48.1M
$1.89M 0.28%
3,808
-105
-3% -$55.4K
TBRA
89
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$1.89M 0.28%
187,622
+50,000
+36% +$519K
PVLA
90
Palvella Therapeutics
PVLA
$1.99B
$1.85M 0.27%
10,125
-1,125
-10% -$189K
ALPN
91
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.79M 0.26%
57,887
+7,457
+15% +$255K
OCRX
92
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1.72M 0.25%
550,000
+50,000
+10% +$171K
TRIL
93
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.67M 0.24%
132,300
-14,700
-10% -$204K
GWPH
94
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.65M 0.24%
23,790
-19,310
-45% -$1.57M
ALDX icon
95
Aldeyra Therapeutics
ALDX
$92.9M
$1.62M 0.24%
238,500
-26,500
-10% -$178K
TSRO
96
DELISTED
TESARO, Inc.
TSRO
$1.6M 0.24%
30,686
-86,814
-74% -$4.15M
NVS icon
97
Novartis
NVS
$297B
$1.55M 0.23%
20,088
-2,232
-10% -$177K
NBRV
98
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.5M 0.22%
630
-70
-10% -$171K
AXTA icon
99
Axalta
AXTA
$7.66B
$1.5M 0.22%
56,173
+15,547
+38% +$434K
NXPI icon
100
NXP Semiconductors
NXPI
$57.8B
$1.43M 0.21%
+16,920
New +$1.45M
2 3
4
5 6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sphera Funds Management held 153 positions worth $683M, down 13% from $784M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sphera Funds Management withdrew a net $82.5M in Q4 2015, closing 35 positions and reducing 53 holdings. Its most notable exit was Elbit Systems, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 56% a quarter earlier, followed by Utilities and Technology.

Against the trend, Sphera Funds Management opened a new position in Alphabet (Google) Class C worth $5.76M.

  • Sphera Funds Management's largest Q4 2015 buy was Alphabet (Google) Class C: 148,180 shares worth $5.76M.
  • Sphera Funds Management added most to Pfizer in Q4 2015, an estimated $20M increase.
  • Sphera Funds Management's biggest Q4 2015 reduction was Shire pic, cutting an estimated $27M.
  • Sphera Funds Management fully exited Elbit Systems in Q4 2015, selling an estimated $29.2M.
  • Sphera Funds Management's ten largest holdings make up 52% of its $683M portfolio in Q4 2015.
  • Sphera Funds Management opened 26 new positions and closed 35 in Q4 2015.
  • Sphera Funds Management's portfolio value fell 13% quarter-over-quarter to $683M.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.